ImmunityBio, Inc. — Director's Dealing 2020

Aug 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2020-08-19

Reporting Person: Thomas John C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-19	Common Stock	S	20000	$9.19	Disposed	250069	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13886	Indirect

Footnotes

F1: Sales made in order to satisfy tax payments paid, accrued and/or owed by the reporting person.

F2: Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96.